Thermo Fisher Scientific Inc (TMO) Stake Lowered by Sumitomo Mitsui Asset Management Company LTD

Sumitomo Mitsui Asset Management Company LTD cut its holdings in Thermo Fisher Scientific Inc (NYSE:TMO) by 7.0% during the third quarter, according to its most recent Form 13F filing with the SEC. The firm owned 39,251 shares of the medical research company’s stock after selling 2,964 shares during the period. Sumitomo Mitsui Asset Management Company LTD’s holdings in Thermo Fisher Scientific were worth $7,426,000 as of its most recent filing with the SEC.

Other institutional investors have also bought and sold shares of the company. Proficio Capital Partners LLC increased its stake in shares of Thermo Fisher Scientific by 71.5% in the first quarter. Proficio Capital Partners LLC now owns 607 shares of the medical research company’s stock worth $105,000 after purchasing an additional 253 shares during the period. Cribstone Capital Management LLC increased its stake in shares of Thermo Fisher Scientific by 8.7% in the second quarter. Cribstone Capital Management LLC now owns 625 shares of the medical research company’s stock worth $109,000 after purchasing an additional 50 shares during the period. Shine Investment Advisory Services Inc. bought a new position in shares of Thermo Fisher Scientific in the second quarter worth about $113,000. Chicago Partners Investment Group LLC bought a new position in shares of Thermo Fisher Scientific in the second quarter worth about $108,000. Finally, Ropes Wealth Advisors LLC increased its stake in shares of Thermo Fisher Scientific by 15.8% in the second quarter. Ropes Wealth Advisors LLC now owns 710 shares of the medical research company’s stock worth $124,000 after purchasing an additional 97 shares during the period. Institutional investors and hedge funds own 85.32% of the company’s stock.

A number of equities research analysts recently weighed in on the company. Leerink Swann lifted their target price on Thermo Fisher Scientific from $190.00 to $207.00 and gave the stock an “outperform” rating in a research report on Monday, October 9th. Zacks Investment Research raised Thermo Fisher Scientific from a “hold” rating to a “buy” rating and set a $212.00 target price on the stock in a research report on Thursday, September 21st. Cowen and Company reissued an “outperform” rating and set a $220.00 target price (up from $200.00) on shares of Thermo Fisher Scientific in a research report on Sunday, September 10th. Deutsche Bank AG set a $226.00 target price on Thermo Fisher Scientific and gave the stock a “buy” rating in a research report on Thursday, October 26th. Finally, BidaskClub downgraded Thermo Fisher Scientific from a “strong-buy” rating to a “buy” rating in a research report on Monday, July 31st. One analyst has rated the stock with a hold rating and sixteen have issued a buy rating to the company. The stock has a consensus rating of “Buy” and a consensus target price of $205.71.

Shares of Thermo Fisher Scientific Inc (NYSE TMO) opened at $190.17 on Monday. The company has a debt-to-equity ratio of 0.85, a quick ratio of 0.81 and a current ratio of 1.26. The firm has a market capitalization of $76,257.29, a P/E ratio of 20.90, a price-to-earnings-growth ratio of 1.74 and a beta of 1.08. Thermo Fisher Scientific Inc has a 1-year low of $139.07 and a 1-year high of $201.20.

Thermo Fisher Scientific (NYSE:TMO) last released its quarterly earnings data on Wednesday, October 25th. The medical research company reported $2.31 earnings per share for the quarter, beating analysts’ consensus estimates of $2.24 by $0.07. The company had revenue of $5.12 billion for the quarter, compared to the consensus estimate of $5.03 billion. Thermo Fisher Scientific had a return on equity of 15.94% and a net margin of 11.73%. The company’s quarterly revenue was up 13.9% on a year-over-year basis. During the same period in the previous year, the business earned $2.03 earnings per share. equities research analysts predict that Thermo Fisher Scientific Inc will post 9.36 EPS for the current fiscal year.

The business also recently disclosed a quarterly dividend, which will be paid on Monday, January 15th. Shareholders of record on Friday, December 15th will be issued a dividend of $0.15 per share. This represents a $0.60 dividend on an annualized basis and a yield of 0.32%. The ex-dividend date of this dividend is Thursday, December 14th. Thermo Fisher Scientific’s payout ratio is 10.19%.

In other news, VP Seth H. Hoogasian sold 4,140 shares of Thermo Fisher Scientific stock in a transaction that occurred on Monday, August 28th. The shares were sold at an average price of $177.80, for a total value of $736,092.00. Following the completion of the transaction, the vice president now owns 25,518 shares in the company, valued at $4,537,100.40. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Marc N. Casper sold 50,000 shares of Thermo Fisher Scientific stock in a transaction that occurred on Wednesday, November 15th. The shares were sold at an average price of $188.39, for a total transaction of $9,419,500.00. Following the completion of the transaction, the chief executive officer now owns 252,577 shares of the company’s stock, valued at approximately $47,582,981.03. The disclosure for this sale can be found here. Insiders have sold 60,420 shares of company stock worth $11,308,477 over the last ninety days. Company insiders own 0.49% of the company’s stock.

ILLEGAL ACTIVITY WARNING: “Thermo Fisher Scientific Inc (TMO) Stake Lowered by Sumitomo Mitsui Asset Management Company LTD” was originally posted by Sports Perspectives and is the sole property of of Sports Perspectives. If you are reading this piece of content on another website, it was illegally stolen and reposted in violation of US and international trademark & copyright legislation. The original version of this piece of content can be read at https://sportsperspectives.com/2017/11/20/thermo-fisher-scientific-inc-tmo-stake-lowered-by-sumitomo-mitsui-asset-management-company-ltd.html.

Thermo Fisher Scientific Company Profile

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Want to see what other hedge funds are holding TMO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc (NYSE:TMO).

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Ratings for Thermo Fisher Scientific Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific Inc and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply